Skip to main content

Cannabis Bioscience International Holdings, Inc.

corporate_fare Company Profile

Cannabis Bioscience International Holdings, Inc.

CBIH·OTC·Life Sciences·CIK 0001411057

Cannabis Bioscience International Holdings, Inc. operates three distinct businesses. The company was initially formed in Colorado on February 28, 2003, as Fidelity Aircraft Partners LLC, later converting to Fidelity Aviation Corporation on December 16, 2009. It subsequently changed its name to China Infrastructure Construction Corp. on August 24, 2004, then to Hippocrates Direct Healthcare, Inc. on February 28, 2018, and finally to Cannabis Bioscience International Holdings, Inc. on December 6, 2022. Its first business, known as the Pharmacology University Business, focuses on cannabis-related research and education under the trade name Pharmacology University. The second business, the Alpha Research Business, conducts clinical trials, some of which may involve cannabis and CBD products, acting as both a Sponsor and a Contract Research Organization (CRO) under the trade name Alpha Research Institute. The third business, the CBD Business, plans to manufacture, market, and sell CBD products under the name "VitaCookies." The company has filed 10 utility patent applications with the U.S. Patent and Trademark Office (USPTO) and plans to file 10 additional applications. It also holds 12 U.S. trademarks.

Cannabis Bioscience International Holdings, Inc. (OTC:CBIH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for CBIH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-22, rated 7/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for CBIH spans 10-Q.

Recent high-impact activity:

  • CBIH Signs First VitaCookies Licensing Deal, Initiating Commercial Rollout
  • Cannabis Bioscience International Holdings Reports Near-Zero Cash, Worsening Financials, and Ineffective Controls Amidst Going Concern Warning
  • Going Concern Warning, Ineffective Controls, and Deteriorating Financials Highlight Severe Risks

Financial Snapshot

Fiscal year ended May 31, 2025
Revenue
$303.02K
Net Income
-$548.82K
Diluted EPS
-$0.00
Op. Cash Flow
-$329.63K
Gross Profit
$262.92K
Operating Income
-$421.37K
Cash & Equivalents
$12.95K
Total Debt
$264.09K
Debt / Equity
-0.23×
Net Margin
-181.1%
Shares Outstanding
11.63B sh
Source: 10-K · filed 2025-09-22 · accession 0001683168-25-007174

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 10,000 shares in CBIH as of the September 15, 2026 settlement, a 100.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On September 28, 2026, 66.7% of CBIH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)10,000 shares as of September 15, 2026
Change vs prior period▲ 100.0%
Days to cover1.00 at avg daily volume of 1,098,597
Daily short volume (FINRA facilities)66.7% of 30,000 shares on September 28, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$0.0002
52-week range · as of 2026-04-16 $0.0002 – $0.0008
Market cap
$2.44M
Volume
20K (0.0× avg)
3-mo avg 710.3K
Live data · 2026-10-05 00:05 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CBIH - Latest Insights

CBIH
Jun 22, 2026, 7:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.0003
Real-time Price: $0.0002 info
Change: -$0.0001 (-33%) info
Market Cap: $2.443M info
CBIH
Apr 16, 2026, 3:39 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0004
Real-time Price: $0.0002 info
Change: -$0.0002 (-50%) info
Market Cap: $2.443M info
CBIH
Feb 19, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0004
Real-time Price: $0.0002 info
Change: -$0.0002 (-50%) info
Market Cap: $2.443M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets